30,853 Shares in Astera Labs, Inc. $ALAB Bought by Empowered Funds LLC

Empowered Funds LLC acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, Holdings Channel reports. The firm acquired 30,853 shares of the company’s stock, valued at approximately $14,903,000.

Other large investors have also bought and sold shares of the company. Glenmede Trust Co. NA grew its position in shares of Astera Labs by 2.7% in the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after buying an additional 51 shares during the last quarter. Keating Financial Advisory Services Inc. bought a new stake in Astera Labs in the second quarter valued at approximately $25,000. Lido Advisors LLC boosted its holdings in Astera Labs by 0.5% in the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after acquiring an additional 57 shares during the last quarter. Transamerica Financial Advisors LLC acquired a new stake in Astera Labs during the 2nd quarter valued at approximately $35,000. Finally, Goldstein Advisors LLC increased its position in Astera Labs by 5.8% during the 4th quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after purchasing an additional 88 shares during the period. 60.47% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on ALAB. Susquehanna boosted their price target on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research report on Friday, July 31st. UBS Group restated a “neutral” rating and issued a $425.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target on the stock in a research report on Monday, August 17th. Rothschild & Co Redburn assumed coverage on Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective for the company. Finally, Citigroup restated a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $340.53.

Astera Labs Trading Down 4.8%

ALAB opened at $289.47 on Friday. The company has a fifty day moving average price of $342.38 and a two-hundred day moving average price of $249.65. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The company has a market cap of $50.22 billion, a P/E ratio of 143.30 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same period last year, the business posted $0.44 EPS. The firm’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the sale, the director owned 75,688 shares in the company, valued at $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer directly owned 1,266,665 shares in the company, valued at $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 419,244 shares of company stock valued at $163,135,169. 10.40% of the stock is currently owned by corporate insiders.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.